Eric Venker
DirectoratImmunovant· In proxies 2023–2025
Eric Venker sits on 3 public boards.
Boards1
- ImmunovantDirector · 4 yr on the boardNot independentNominating and Corporate Governance—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- ImmunovantPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +410%
- Arbutus BiopharmaPublic company
- Director? – PresentNo stock prices for these years
- Sio Gene Therapies, Inc.Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?